Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05461196 · ClinicalTrials.gov registry record · NA
Decreasing Opioid Misuse and Habit-forming Behaviors Following Prescription in Patients Undergoing Cesarean Section
A NA study of Opioid Misuse, sponsored by Jessica Morgan.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05461196 is a NA study of Opioid Misuse that has completed, run by Jessica Morgan. The registered enrollment target is 100 participants, below the 5,983-participant average among 13 other Opioid Misuse trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05461196, a NA study of Opioid Misuse, has completed, sponsored by Jessica Morgan.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Cesarean delivery is one of the most common obstetric procedures experienced among women who are pregnant.1 Women with Cesarean deliveries have a higher rate of peripartum opioid prescriptions and persistent opioid use compared to those with vaginal deliveries.2 Since 2002, prescription opioid use and misuse has significantly increased among women, including those who are pregnant, showing over 31% increase in past-month heroin use among women of childbearing age.3 This indicates the importance of focusing on maternal population for prescribed opioid medication management during the immediate postpartum period to prevent long-term persistent opioid misuse. Few evidence-based approaches are available to remotely manage prescription opioid use post-discharge.4 Recent advances in mobile technology have made it possible to monitor behavior and maintain communication in near real-time, long after patients are discharged from their surgical procedures.5-7 Using a virtual platform via use of mobile technology offers potential for sustainable implementation of a behavioral intervention and patient-provider communication even during the COVID-19 pandemic.8 Continuous Precision Medicine (CPM™; Research Triangle Park, NC) has developed a mobile app to overcome these barriers for tracking pain and pain medication use among post-surgery patients and tested the logistical and technological feasibility in postpartum patients at Temple OB/GYN. Collectively, our team brings expertise and collaborations between Temple University Hospital, RTI International, and CPM for the following Specific Aims: Aim 1: To examine the preliminary impact of the CPM mobile app to reduce the use of opioids among women post-Cesarean surgery Hypothesis 1: Patients using the CPM application will use fewer Morphine Milligram Equivalents (MME) compared to the blister package group. Aim 2: To establish correlates of pain medication use among women post-Cesarean surgery to estimate the appropria
Conditions Studied
Interventions
- BEHAVIORAL CPMRx
Study Locations (1)
Pennsylvania
- Temple University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-05-12 |
| Est. Completion | 2022-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05461196
The ClinicalTrials.gov registry entry for NCT05461196 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,983-participant average among 13 other Opioid Misuse trials with a reported enrollment target (98% lower). The listed sponsor is Jessica Morgan, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Misuse appearing as the primary indexed condition, and to 1 intervention - of which CPMRx is the first listed.
NCT05461196 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05461196 about?
NCT05461196 is a clinical study titled "Decreasing Opioid Misuse and Habit-forming Behaviors Following Prescription in Patients Undergoing Cesarean Section". Background: Cesarean delivery is one of the most common obstetric procedures experienced among women who are pregnant.1 Women with Cesarean deliveries have a higher rate of peripartum opioid prescriptions and persistent opioid use compared to those with vaginal deliveries.2 Since 2002, prescription ...
What is the current status of trial NCT05461196?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2021-05-12. Estimated completion is 2022-08-01.
What conditions does trial NCT05461196 study?
This clinical trial studies the following conditions: Opioid Misuse.
What interventions are being tested in trial NCT05461196?
The interventions under investigation include: CPMRx (BEHAVIORAL).
Who is sponsoring clinical trial NCT05461196?
This trial is sponsored by Jessica Morgan, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05461196 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Misuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
-
M2VA Pain Care Pathway
RECRUITING · NA
-
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
RECRUITING · NA
-
Pain Care at Home to Amplify Function (Pain CHAMP)
ACTIVE NOT RECRUITING · NA
-
Healthy Opioid Prescription Engagement
ACTIVE NOT RECRUITING · NA
-
Reduced Opioid Prescription After Laparoscopic Hysterectomy
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.